Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Clinical Research in Southampton
Southampton Children's Hospital
A
A
A
Text only
| Accessibility | Privacy and cookies
"Helpful, informative, polite and friendly staff put my mind at ease"
Patient feedback
Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us
You are here:
Home
>
Search results
Search
Browse site A to Z
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Search results
Go To Advanced Search
Search
You could also try:
indicative (22)
,
suggestive (83)
NilotinibAccelerated
Description
Chemotherapy Protocol Chronic Myeloid Leukaemia Nilotinib (accelerated phase) Regimen • CML – Nilotinib (accelerated phase) Indication • Nilotinib is an o
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/NilotinibAccelerated.pdf
ImatinibChronic
Description
Chemotherapy Protocol Chronic Myeloid Leukaemia Regimen IMATINIB (chronic phase) • CML – Imatinib (chronic phase) Indication • As the preferred first-line
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/ImatinibChronic.pdf
ImatinibAccelerated
Description
Chemotherapy Protocol Chronic Myeloid Leukaemia Regimen IMATINIB (accelerated phase) • CML - Imatinib (accelerated phase) Indication • As the preferred op
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/ImatinibAccelerated.pdf
DasatinibChronic
Description
Chemotherapy Protocol Chronic Myeloid Leukaemia DASATINIB (chronic phase) Funding may be required for specific indications Regimen •
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/DasatinibChronic.pdf
DasatinibAccelerated
Description
Chemotherapy Protocol Chronic Myeloid Leukaemia DASATINIB (accelerated phase) Funding may be required for specific indications Regime
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/DasatinibAccelerated.pdf
Bosutinib
Description
Chemotherapy Protocol Chronic Myeloid Leukaemia Bosutinib Regimen • Bosutinib Indication • As an option for the treatment of patients with chronic phase, accelerated
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/Bosutinib.pdf
Lomustine-Procarbazine ver 1.1
Description
Chemotherapy Protocol Central Nervous System LOMUSTINE-PROCARBAZINE Regimen CNS – Lomustine-Procarbazine Indication Adjuvant treatment for
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CNS/Lomustine-Procarbazine-ver-1.1.pdf
Capecitabine 1250 (14)
Description
Chemotherapy Protocol BREAST CANCER CAPECITABINE 1250 (14 day) Regimen • Breast Cancer – Capecitabine 1250 (14 day) In
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Capecitabine1250-14.pdf
Capecitabine 1000 (14)
Description
Chemotherapy Protocol BREAST CANCER CAPECITABINE 1000 (14 day) Regimen • Breast Cancer – Capecitabine 1000 (14 day
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Capecitabine1000-14.pdf
Topotecan (Oral)
Description
Chemotherapy Protocol LUNG CANCER – SMALL CELL (SCLC) TOPOTECAN (Oral) Regimen • SCLC – Topotecan PO Indicatio
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-small-cellSCLC/Topotecan-Oral.pdf
251
to
260
of
527
Previous
…
24
25
26
27
28
…
Next
Site policies
Report a problem with this page
Privacy and cookies
Site map
Translation
Last updated: 14 September 2019
Contact details
University Hospital Southampton NHS Foundation Trust
Tremona Road
Southampton
Hampshire
SO16 6YD
Telephone: 023 8077 7222
Useful links
Home
Getting here
What to do in an emergency
Research
Working here
Education
© 2014 University Hospital Southampton NHS Foundation Trust
Browser does not support script.
Browser does not support script.